Craft

Li Kang Biomedical

Stock Price

NT$43

2024-10-29

Market Capitalization

NT$1.4 B

2024-10-29

Revenue

NT$589.2 M

FY, 2025

Li Kang Biomedical Summary

Company Summary

Overview
Li Kang Biomedical (立康生醫事業股份有限公司, formerly known as BAFO Technologies) is a manufacturer and retailer of supplements, cosmeceuticals, and hygienic drinks. It is also engaged in the management and consulting of tourism factory business and offers telemarketing services.
Type
Public
Status
Active
Founded
1982
Website
http://likangbio.com
Cybersecurity rating
Sectors

Table of Contents

Li Kang Biomedical Financials

Summary Financials

Revenue (FY, 2025)
NT$589.2M
Gross profit (FY, 2025)
NT$409.4M
Net income (FY, 2025)
NT$83.8M
Cash (FY, 2025)
NT$42.9M
EBIT (FY, 2025)
NT$100.2M
Enterprise value
$1.5B

Footer menu